Literature DB >> 7721749

Transcriptional analysis of acetylcholine receptor alpha 3 gene promoter motifs that bind Sp1 and AP2.

X Yang1, D Fyodorov, E S Deneris.   

Abstract

In this study, we performed an analysis of the neuronal nicotinic acetylcholine receptor alpha 3 subunit gene promoter region, -238/+47, to identify cis and trans elements that are important for basal activity in PC12 cells. Sequence analyses of the alpha 3 promoter and footprint assays revealed an Sp1 binding site between -79 and -57 (termed the alpha 3 GA motif) and an AP2 binding site between -30 and -7. Using mobility shift analysis, we found that PC12 cell extracts contain proteins that specifically bind to the alpha 3 GA motif and are immunologically related to Sp1. Mutation of the alpha 3 GA motif, which prevented binding of Sp1, resulted in a 75% decrease in promoter activity. Mutation of the AP2 site resulted in only a minor loss of promoter activity, which is consistent with the lack of AP2 binding activity in PC12 extracts. In Drosophila Schneider line 2 (S2) cell cotransfection assays, Sp1 activated the alpha 3 promoter in a GA motif-dependent manner. Furthermore, multimerization of the GA motif upstream of the beta-globin TATA box conferred Sp1 responsiveness. Our results indicate that Sp1 can activate transcription through direct interaction with the alpha 3 GA motif and that this motif plays a major role in alpha 3 promoter basal activity in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721749     DOI: 10.1074/jbc.270.15.8514

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Regulation of ion channel expression in neural cells by hormones and growth factors.

Authors:  L J Chew; V Gallo
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

2.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

Review 3.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

4.  Shared long-range regulatory elements coordinate expression of a gene cluster encoding nicotinic receptor heteromeric subtypes.

Authors:  Xiaohong Xu; Michael M Scott; Evan S Deneris
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

5.  Overlapping Sp1 and AP2 binding sites in a promoter element of the lens-specific MIP gene.

Authors:  C Ohtaka-Maruyama; X Wang; H Ge; A B Chepelinsky
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

6.  beta43': An enhancer displaying neural-restricted activity is located in the 3'-untranslated exon of the rat nicotinic acetylcholine receptor beta4 gene.

Authors:  J McDonough; E Deneris
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

7.  Structure and alternative promoters of the mouse glutamic acid decarboxylase 67 gene.

Authors:  Y Yanagawa; T Kobayashi; T Kamei; K Ishii; M Nishijima; A Takaku; S Tamura
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 8.  The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.

Authors:  Ma Reina D Improgo; Michael D Scofield; Andrew R Tapper; Paul D Gardner
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

Review 9.  Acetylcholinesterase in Hirschsprung's disease.

Authors:  S W Moore; G Johnson
Journal:  Pediatr Surg Int       Date:  2005-03-10       Impact factor: 1.827

10.  Temporally- and spatially-regulated transcriptional activity of the nicotinic acetylcholine receptor beta4 subunit gene promoter.

Authors:  L Bruschweiler-Li; Y F Fuentes Medel; M D Scofield; E B T Trang; S A Binke; P D Gardner
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.